Definitive Contract 75A50120C00123
Award Date
6/12/20
Potential Completion Date
9/30/20
Potential Value
$678K
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a $2,335,000.00 firm fixed price purchase order to Ortho-Clinical Diagnostics, Inc. to advance the company's VITROS immunodiagnostic products assay for the detection of SARS-CoV-2 antigen through the de novo 510(k) submission process. The award, which has an ultimate completion date of April 15, 2022, is not associated with a set-aside program. Ortho-Clinical...
The U.S. Department of Health and Human Services has awarded a firm fixed price purchase order contract worth $97,302.80 to Ortho-Clinical Diagnostics, Inc. for drugs and biologicals. The contract has an ultimate completion date of May 17, 2017. Ortho-Clinical Diagnostics is a medical equipment manufacturing company that provides diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry analyzers. They have delivered similar products and services to various federal...
Ortho-Clinical Diagnostics Inc. has been awarded a firm fixed price contract by the General Services Administration Federal Acquisition Service to deliver reagents in support of coronavirus COVID-19 testing. Valued at $15,973.31, the contract was awarded on April 3, 2020 under the Blanket Purchase Agreement with a period of performance through April 10, 2020. The reagents will be delivered to a location in Raritan, New Jersey to support testing efforts for both military and civilian customers...
The U.S. Department of Health and Human Services, National Institutes of Health Clinical Center awarded a firm fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc. for $117,503.84. The contract is under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule and does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturer that provides a range of diagnostic solutions, including the QuickVue At...
This federal contract award to Ortho-Clinical Diagnostics Inc. was issued by the Department of Health and Human Services Centers for Disease Control and Prevention for the purchase of laboratory supplies. The contract has a potential value of $144,287.64 and was awarded on a firm fixed price basis with no set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including the QuickVue At HomeTM COVID-19 Test and VITROS...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Delivery Order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer, for the supply of lab reagents. The $144,287.64 contract has an October 30, 2018 completion date and was awarded on July 23, 2018. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including products such as the QuickVue At HomeTM COVID-19 Test, to federal agencies...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract, which has a potential value of $177,950.76, is to provide reagents for the National Health and Nutrition Examination Survey (NHANES) program. The order is placed under Ortho-Clinical Diagnostics' existing Critical Analyzers, Laboratory (FSS-66-III) schedule...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price delivery order to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer, for the delivery of a chemistry analyzer. The potential value of the contract is $822,091.76, and the place of performance is Raritan, NJ. Ortho-Clinical Diagnostics Inc. is a for-profit organization and a self-certified HUBZone joint venture that manufactures a range of diagnostic solutions, including the QuickVue At Home...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, to provide reagents and consumables. The $184,454.73 contract was awarded on May 12, 2020 and has a completion date of December 24, 2020. No set-aside designation was used. Ortho-Clinical Diagnostics has provided a wide range of diagnostic solutions, including COVID-19 testing...
This is a firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Ortho-Clinical Diagnostics, Inc. for the provision of cost-per-test services for a VITROS 350 analyzer. The award, valued at $253,387.70, was made under the Critical Analyzers, Laboratory (FSS-66-III) blanket purchase agreement and has an ultimate completion date of May 15, 2021. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions,...